Imunon, Inc.
IMNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000749647
In the last 90 days, Imunon, Inc. insiders filed 0 open-market purchases and 5 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $506.1K in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Imunon, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- +1 vs. Q2 2023
- Shares held
- 412.5K
- +12.8K (+3.2%) vs. Q2 2023
- Total value
- $402.9K
- −$112.2K (−21.8%) vs. Q2 2023
- New holders
- 2
- 3 more added
- Sold out
- 1
- 6 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMNN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $506.1K |
| Q1 2026 | 19 | $1.63M |
| Q4 2025 | 20 | $1.76M |
| Q3 2025 | 17 | $879.0K |
| Q2 2025 | 26 | $1.76M |
| Q1 2025 | 19 | $359.9K |
| Q4 2024 | 22 | $403.5K |
| Q3 2024 | 22 | $1.08M |
| Q2 2024 | 18 | $442.0K |
| Q1 2024 | 18 | $539.4K |
| Q4 2023 | 22 | $285.9K |
| Q3 2023 | 18 | $402.9K |
| Q2 2023 | 17 | $515.1K |
| Q1 2023 | 19 | $513.3K |
| Q4 2022 | 22 | $572.7K |
| Q3 2022 | 22 | $818.1K |
| Q2 2022 | 25 | $1.69M |
| Q1 2022 | 24 | $2.66M |
| Q4 2021 | 42 | $4.14M |
| Q3 2021 | 40 | $8.54M |
| Q2 2021 | 43 | $11.5M |
| Q1 2021 | 47 | $16.4M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Imunon, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 121,846 | $119.7K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 84,911 | $83.0K | 0.00% | +10,900+14.7% | Added |
| Geode Capital Management, LLC | 66,595 | $64.5K | 0.00% | +17,666+36.1% | Added |
| BlackRock Inc. | 58,584 | $57.6K | 0.00% | −8,573−12.8% | Reduced |
| Citadel Advisors LLC | 44,876 | $43.5K | 0.00% | −6,798−13.2% | Reduced |
| State Street Corp | 14,303 | $13.9K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 10,736 | $10.4K | 0.00% | −126−1.2% | Reduced |
| Tower Research Capital LLC (TRC) | 8,350 | $8.20K | 0.00% | −61−0.7% | Reduced |
| Morgan Stanley | 1,631 | $1.60K | 0.00% | 00.0% | Unchanged |
| M&R Capital Management Inc | 333 | $327 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 129 | $125 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 68 | $67 | 0.00% | +2+3.0% | Added |
| Federation des caisses Desjardins du Quebec | 66 | $65 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 21 | $21 | 0.00% | −240−92.0% | Reduced |
| JPMorgan Chase & Co | 11 | $11 | 0.00% | +11 | New |
| FMR LLC | 6 | $6 | 0.00% | +6 | New |
| Advisor Group Holdings, Inc. | 2 | $1 | 0.00% | −12−85.7% | Reduced |
| Royal Bank of Canada | 4 | $0 | 0.00% | 00.0% | Unchanged |
| NewSquare Capital LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |